PE-conjugated Anti-PCSK9(evolocumab biosimilar) mAb

Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: PE-conjugated Anti-PCSK9(evolocumab biosimilar) mAb

Storage & Shipping: Store at 2°C-8°C fo 6 months

Formulation & Reconstitution: Liquid，PBS with 0.05% Proclin300, 527% BSA

Target: PCSK9

Uniprot ID: Q8NBP7

Usage: Research use only

Recommended Dilutions: Flow Cyt 1:100

Common Name: AMG-145AMG145Repatha

Guarantee: 6 months from date of dispatch

• Artikelnummer: DMABME100501P-100
• Hersteller: DIMA Biotechnology
• Hersteller Artikelnummer: BME100501P-100
• Verpackungseinheit: 100 test
• Mengeneinheit: STK
• Reaktivität: Human
• Methode: Flow Cytometry
• Isotyp: IgG2
• Konjugat: Conjugated, PE (Phycoerythrin)